Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-050002

Director bought 57,100 shares at an average $104.43 ($5,963,124)

From the SEC's structured data for this filing

Trades in this filing

Chambers Michael Andrew · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-14 Purchase : show line 1 in the form +20,744 $103.87 $2,154,679 71,822 D
2022-09-14 Purchase : show line 2 in the form +30,106 $104.67 $3,151,195 101,928 D
2022-09-14 Purchase : show line 3 in the form +6,250 $105.16 $657,250 108,178 D
Open-market purchases · 57,100 sh · avg $104.43 · $5,963,124
Loading xslF345X03/doc4.xml…